Aequita Pharmacy
Kirkland, WA pharmacy that news outlets describe as Mochi Health-owned or Mochi-affiliated. At its peak it shipped Mochi-branded compounded GLP-1s nationwide, and it closed in April 2025 after Washington regulators acted.
Makes or dispenses: semaglutide, tirzepatide
Telehealth brands that use Aequita Pharmacy
FDA and regulatory record
Warning letters and Form 483s record problems FDA found during an inspection at the time. They don't by themselves mean the medication you receive today is unsafe, and pharmacies often fix the issues. Check the dates, and read the source documents.
- Apr 2025 · State action
Washington State Department of Health issued a Notice of Immediate Jeopardy over unlicensed workers, unsafe and unsanitary conditions and imported GLP-1 base powders. The pharmacy closed in April 2025 (exact notice date not given; recorded as April 2025). Its owner-pharmacist signed an Agreed Order in July 2025, per KING 5 / NBC reporting.
Source →
Questions about Aequita Pharmacy
Which telehealth companies use Aequita Pharmacy?
▾
Among the brands we track: Mochi Health. Some of these links come from patient reports rather than the brand itself; they're marked on this page.
What kind of pharmacy is Aequita Pharmacy?
▾
Aequita Pharmacy is listed as: brand-owned pharmacy, based in Kirkland, WA. 503A pharmacies compound medication for individual patient prescriptions under state board oversight; 503B outsourcing facilities register with the FDA and follow federal manufacturing standards (CGMP).
Has Aequita Pharmacy received FDA warning letters?
▾
We found 1 regulatory record, the most recent dated Apr 2025. Each is listed on this page with a link to the source document.
Sources
- https://www.nbcbayarea.com/news/local/mochi-health-weight-loss-drugs-scrutinity/4094754/
- https://www.safemedicines.org/2026/02/february-23-2026.html
Researched 2026-09-26.